Original Article

You have free access to this content

Should “atypical follicular cells” in thyroid fine-needle aspirates be subclassified?

  1. Andrew A. Renshaw MD†,*

Article first published online: 28 JUN 2010

DOI: 10.1002/cncy.20091

Issue

Cancer Cytopathology

Cancer Cytopathology

Volume 118, Issue 4, pages 186–189, 25 August 2010

Additional Information

How to Cite

Renshaw, A. A. (2010), Should “atypical follicular cells” in thyroid fine-needle aspirates be subclassified?. Cancer Cytopathology, 118: 186–189. doi: 10.1002/cncy.20091

Author Information

  1. Department of Pathology, Baptist Hospital of Miami, Miami, Florida

  1. †

    Fax: (786) 596-5986

*Department of Pathology, Baptist Hospital of Miami, 8900 N. Kendall Dr., Miami, FL 33176

Publication History

  1. Issue published online: 16 AUG 2010
  2. Article first published online: 28 JUN 2010
  3. Manuscript Accepted: 13 APR 2010
  4. Manuscript Revised: 5 APR 2010
  5. Manuscript Received: 2 MAR 2010
Corrected by:

Erratum: Erratum: Should “atypical follicular cells” in thyroid fine-needle aspirates be subclassified?

Vol. 118, Issue 5, 303, Article first published online: 9 SEP 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (96K)

REFERENCES

  • 1
    Ali SZ,Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology. New York: Springer; 2010.
  • 2
    Marchevsky AM,Walts AE,Bose S, et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn Cytopathol. 2010; 38: 252-259.
  • 3
    Renshaw AA. Reporting risk of malignancy/dysplasia in cytology: a potential way to improve communication, if not reputation. Cancer. 2007; 111: 465-466.
    Direct Link:
  • 4
    Redman R,Yoder BJ,Massoll NA. Perceptions of diagnostic terminology and cytopathologic reporting of fine-needle aspiration biopsies of thyroid nodules: a survey of clinicians and pathologists. Thyroid. 2006; 16: 1003-1008.
  • 5
    Marhefka GD,McDivitt JD,Shakir KM,Drake AJ3rd. Diagnosis of follicular neoplasm in thyroid nodules by fine needle aspiration cytology: does the result, benign vs. suspicious for a malignant process, in these nodules make a difference? Acta Cytol. 2009; 53: 517-523.
  • 6
    Renshaw AA. How closely do thyroid fine needle aspirates need to be screened? Diagn Cytopathol. 2002; 27: 259-260.
    Direct Link:
  • 7
    Renshaw AA. Accuracy of thyroid fine-needle aspiration using receiver operator chracteristic curves. Am J Clin Pathol. 2001; 116: 477-482.
  • 8
    Renshaw AA. Focal features of papillary carcinoma of the thyroid in fine needle aspiration material are strongly associated with papillary carcinoma at resection. Am J Clin Pathol. 2002; 118: 208-210.
  • 9
    Wu HH,Jones JN,Grzybicki DM,Elsheikh TM. Sensitive cytologic criteria for the identification of follicular variant of papillary thyroid carcinoma in fine-needle aspiration biopsy. Diagn Cytopathol. 2003; 29: 262-266.
    Direct Link:
  • 10
    Renshaw AA. Hurthle cell carcinoma is a better gold standard than Hurthle cell neoplasm for thyroid fine needle aspirates: defining more consistent and specific cytologic criteria. Cancer Cytopathol. 2002; 96: 261-266.
  • 11
    Renshaw AA,Pinnar N. Comparison of thyroid fine needle aspiration and core needle biopsy. Am J Clin Pathol. 2007; 128: 370-374.
  • 12
    Renshaw AA. Does a Repeat Aspirate Change the Risk of Malignancy After an Initial Atypical Thyroid Fine Needle Aspiration? Cancer Cytopathol. 2010: This issue.
    Direct Link:
View Full Article (HTML) Get PDF (96K)